Phase 2 Study of a Live Attenuated Measles Virus-Vectored Chikungunya Vaccine in a Previously Epidemic Area
Phase of Trial: Phase II
Latest Information Update: 31 Jul 2019
Price : $35 *
At a glance
- Drugs Chikungunya virus vaccine (Primary) ; Measles mumps and rubella virus vaccine
- Indications Chikungunya virus infections
- Focus Adverse reactions
- Sponsors Themis Bioscience
- 29 Jul 2019 Status changed from active, no longer recruiting to completed.
- 19 Jun 2018 Status changed from recruiting to active, no longer recruiting.
- 17 Aug 2017 Status changed from not yet recruiting to recruiting.